Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool.
Transient Brain Lesions in Neuro-Behçet's Disease without Systemic Involvement.
Multiple Sclerosis Lesions in the Brain: Computer-Assisted Assessment of Lesion Load Dynamics on 3D FLAIR MR Images.
Cross-reactivity between human cytomegalovirus peptide 981-1003 and myelin oligodendroglia glycoprotein peptide 35-55 in experimental autoimmune encephalomyelitis in Lewis rats.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
Structure-Kinetics Relationships - an overlooked parameter in hit-to-lead optimization: a case of cyclopentylamines as CCR2 antagonists.
Multiple sclerosis : A multielement survey.
Optimizing therapeutics in the management of patients with multiple sclerosis: a review of drug efficacy, dosing, and mechanisms of action.
The role of staphylococcal enterotoxin A in achieving oral tolerance to myelin basic protein in adult mice.
Behavioral Symptoms in Pediatric Multiple Sclerosis: Relation to Fatigue and Cognitive Impairment.
An MRI review of acquired corpus callosum lesions.
Association between stressful life events and exacerbation in multiple sclerosis: a meta-analysis.
Neuromuscular electrical stimulation cycling exercise for persons with advanced multiple sclerosis.
Moving to fingolimod from natalizumab in multiple sclerosis-reply.
Correlations between serum uric Acid level and disease activity, intrathecal inflammation reactivity in patients with multiple sclerosis.
24S-hydroxycholesterol in plasma: A marker of cholesterol turnover in neurodegenerative diseases.
Tumefactive demyelination presenting during bevacizumab treatment.
Dimethyl Fumarate: A Review in Relapsing-Remitting MS.
Age-effects in white matter using associated diffusion tensor imaging and magnetization transfer ratio during late childhood and early adolescence.
[Natalizumap can induce progressive multifocal leucoencephalopathy.]
Symptoms and Association with Health Outcomes in Relapsing-Remitting Multiple Sclerosis: Results of a US Patient Survey.
11C-Acetate PET Imaging in Patients with Multiple Sclerosis.
Emotional Intelligence (EI) of Patients with Multiple Sclerosis (MS).
Comparison of two commercial ELISA systems for evaluating anti-EBNA1 IgG titers.
Multiple sclerosis. Recent modalities of treatment.

Pages